Kochanek PM et al. |
Platelet activating factor antagonists do not alter normal cerebral blood flow or cerebral oxygen consumption. |
1990 |
Adv. Exp. Med. Biol. |
pmid:2096640
|
Camussi G et al. |
Antiflammins inhibit synthesis of platelet-activating factor and intradermal inflammatory reactions. |
1990 |
Adv. Exp. Med. Biol. |
pmid:2096695
|
Kurachi M et al. |
Suppression of bronchial response to platelet activating factor following taurine administration. |
1987 |
Adv. Exp. Med. Biol. |
pmid:3434419
|
Sato S et al. |
Up-regulation of the intracellular Ca2+ signaling and mRNA expression of platelet-activating factor receptor by estradiol in human uterine endometrial cells. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131133
|
Dohi T et al. |
Functional role of platelet-activating factor receptor in secretory response in adrenal chromaffin cells. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131134
|
Lee T |
Acetylation of sphingosine by PAF-dependent transacetylase. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131136
|
Muguruma K et al. |
The prevention of necrotizing enterocolitis. The role of platelet-activating factor acetylhydrolase. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131138
|
Baltas G et al. |
Implication of PAF and acetylhydrolase (PAF-AH) activity in periodontal disease. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131139
|
Ishii I et al. |
High and low affinity mutants of platelet-activating factor receptor. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9561146
|
Marshall LA et al. |
Respective roles of the 14 kDa and 85 kDa phospholipase A2 enzymes in human monocyte eicosanoid formation. |
1999 |
Adv. Exp. Med. Biol. |
pmid:10667333
|
Kato K |
Modulation of long-term potentiation in the CA1 area of rat hippocampus by platelet-activating factor. |
1999 |
Adv. Exp. Med. Biol. |
pmid:10667334
|
Goldman R et al. |
Lipid mediators stimulate reactive oxygen species formation in immortalized human keratinocytes. |
1999 |
Adv. Exp. Med. Biol. |
pmid:10667361
|
Pirotzky E et al. |
Involvement of platelet-activating factor in renal processes. |
1989 |
Adv. Lipid Res. |
pmid:2698054
|
Holleran WM |
Lipid modulators of epidermal proliferation and differentiation. |
1991 |
Adv. Lipid Res. |
pmid:1763711
|
Koltai M et al. |
Platelet-activating factor antagonists: scientific background and possible clinical applications. |
1994 |
Adv. Pharmacol. |
pmid:8080821
|
Summers JB and Albert DH |
Platelet activating factor antagonists. |
1995 |
Adv. Pharmacol. |
pmid:7748804
|
Foegh ML et al. |
Leukotrienes, thromboxane, and platelet activating factor in organ transplantation. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2959038
|
Robertson DN and Smith GM |
Role of thromboxane A2, 5-hydroxytryptamine, and platelet activating factor in collagen-induced sudden death in rabbits. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2959049
|
Matsumoto M and Miwa M |
Platelet-activating factor-binding protein in human serum. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3004155
|
Terashita Z et al. |
Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3004156
|